InflaRx
IFRX
37 hedge funds and large institutions have $82.7M invested in InflaRx in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 4 closing their positions.
1,069% more capital invested
Capital invested by funds: $7.08M → $82.7M (+$75.6M)
325% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 4
213% more call options, than puts
Call options by funds: $1.12M | Put options by funds: $357K
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
48% more funds holding
Funds holding: 25 → 37 (+12)
23.48% more ownership
Funds ownership: 8.09% → 31.57% (+23%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
+$16.1M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$13M |
| 3 |
6CM
683 Capital Management
New York
|
+$8.95M |
| 4 |
EP
Eversept Partners
New York
|
+$8.57M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FSA
Franklin Street Advisors
Chapel Hill,
North Carolina
|
-$112K |
| 2 |
JP Morgan Chase
New York
|
-$90K |
| 3 |
BC
Birchview Capital
Burlington,
Vermont
|
-$89.5K |
| 4 |
Morgan Stanley
New York
|
-$67.7K |
| 5 |
IIA
IPG Investment Advisors
San Diego,
California
|
-$50.2K |
IFRX Hedge Fund Activity: Q2 2023 in Review
37 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q2 2023, worth a combined $82.7M — up 1,069% from $7.08M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new IFRX positions and 4 closed out — a net gain of 13 holders — while 10 added to existing stakes and 5 trimmed.
The largest buyer was Suvretta Capital Management, adding an estimated $16.1M. The largest seller was Franklin Street Advisors, cutting an estimated $112K.
- 37 institutional investors held InflaRx (IFRX) as of Q2 2023, up from 25 in Q1 2023.
- Funds reported $82.7M of InflaRx stock for Q2 2023, up 1,069% quarter-over-quarter.
- 17 funds opened new InflaRx positions in Q2 2023 and 4 closed out, a net change of +13 holders.
- The largest InflaRx buyer in Q2 2023 was Suvretta Capital Management, an estimated $16.1M added.
- The largest InflaRx seller in Q2 2023 was Franklin Street Advisors, an estimated $112K sold.
Based on aggregated 13F filings for Q2 2023.